Table 2: Pooled proportion of chronic clinical comorbidities in COVID-19 patients.
Morbidities |
Crude Proportion (N=2028) |
Pooled Proportion |
||||
n (%) |
95% CI |
Proportion |
95% CI |
p-value |
Heterogeneity I2 (p-Value) |
|
Hypertension (HTN) |
350 (17.26) |
15.64-18.97 |
0.15 |
0.09-0.21 |
0.001 |
93.24 (0.001) |
Diabetes Mellitus (DM) |
205 (10.11) |
8.33-11.50 |
0.11 |
0.08-0.14 |
0.001 |
65.28 (0.001) |
Cardiovascular Disease (CVD)* |
97 (4.78) |
3.90-5.80 |
0.06 |
0.03-0.08 |
0.001 |
75.63 (0.001) |
Cerebrovascular Disease* |
71 (3.50) |
2.74-4.40 |
0.03 |
0.01-0.04 |
0.001 |
88.35 (0.001) |
Chronic Lung Disease* |
44 (2.17) |
1.58-2.90 |
0.02 |
0.01-0.03 |
0.001 |
48.92 (0.034) |
Chronic Liver Disease*¶ |
30 (1.48) |
1.00-2.11 |
NA |
|||
Malignancy*¶ |
27 (1.33) |
0.90-1.93 |
NA |
|||
Chronic Kidney Disease* |
17 (0.84) |
0.49-1.34 |
NA |
|||
Hepatitis B |
23 (1.13) |
0.72-1.70 |
NA |
|||
Digestive System Disorders* |
18 (0.89) |
0.53-1.40 |
NA |
|||
Endocrine System Disorders* |
15 (0.74) |
0.41-1.21 |
NA |
|||
Nervous System* |
8 (0.40) |
0.20-0.78 |
NA |
|||
Immunosuppression* |
2 (0.10) |
0.01-0.36 |
NA |
|||
Rheumatologic Disorders* |
1 (0.05) |
0.00-0.30 |
NA |
|||
Malnutrition |
1 (0.05) |
0.00-0.30 |
NA |
|||
Others |
22 (1.08) |
0.70-1.70 |
NA |